Contact
Sitemap
About us
Health
Products
Community
Careers
Media
Current Releases
Archive
Select language : EN-FR
English
Francais
Facts about Nycomed Canada
Learn more about Nycomed Canada by reading our
fact sheet
.
Latest News
26.04.10
Nycomed and Merck & Co., Inc., announce commercialization agreements for Daxas® in Europe and Canada
Zurich, Switzerland, and Whitehouse Station, N.J, April 26, 2010 – Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced ......
13.04.10
NYCOMED CANADA RECOGNIZED BY ‘BEST WORKPLACES IN CANADA’ LIST 2010
Great Place to Work® Institute Canada Ranks Nycomed as top pharmaceutical employer ...
09.09.09
Four studies published in The Lancet show roflumilast (Daxas), a new oral approach to COPD, improves lung function and reduces exacerbations
Lancet Canadian Press Release ...
Media
Information available to the media and public in this section includes,
Current Releases
and
Archived Releases
, as well as a
Nycomed Canada Fact Sheet
.
Members of the media who wish to contact Nycomed for information, may do so by calling (905) 469-9333 or toll free at 1 (888) 367-3331, or by email at
canadian.communications@nycomed.com
.
Corporate Media
Find Nycomed’s
corporate
press releases, publications, financial reports and upcoming events.
© Nycomed, 2010
Nycomed Canada Inc., 435 North Service Rd. West, 1st floor Oakville, Ontario L6M 4X8